Sanofi: statement on Horizon Therapeutics takeover
(CercleFinance.com) - As required by Rule 2.
12 of the Code, Sanofi confirms that any offer to Horizon Therapeutics, if made by Sanofi, will be solely in cash.
"There is no certainty that any offer will be made, nor as to the terms on which any such offer may be made, if forthcoming," the company said.
Copyright (c) 2022 CercleFinance.com. All rights reserved.